glp-1 news today oct 2 2025 Weight-Loss Drug Demonstration Begins July 2026 GLP-1 Pipeline Update: May 2025

In mouse models, dual agonism had superior efficacy for weight loss and glucose control compared to a GLP-1RA alone 9 , with additive effects of the GIPR proposed to act through signaling in beta cells 10 , alpha cells 11 , the CNS (central nervous system) 12,13 and adipocytes 14

, Glycogen (), ( ) : L-carnitine

Pentadecapeptide BPC 157 tendon-fibroblast model study

Primary carnitine deficiency is a genetic disorder of the cellular carnitine-transporter system that typically appears by the age of five with symptoms of cardiomyopathy, skeletal-muscle weakness, and hypoglycemia

BREATH IN, BREATH OUT Yerba Mate contains Theobromine, which is believed to aid in bronchodilation, thereby improving airflow through the lungs and enhancing respiratory function during exercise

Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism